The Shuman Law Firm today announced that it is investigating potential breaches of fiduciary duty in connection with the proposed acquisition of Advanced Medical Optics, Inc. ("Advanced Medical Optics" or the "Company") (NYSE:EYE).

On January 12, 2009, Advanced Medical Optics announced their intent to sell the Company to Abbott Labs, Inc. (NYSE:ABT). Under the terms of the merger agreement, Advanced Medical Optics shareholders would receive $22 per share in cash for a total sale price of approximately $1.4 billion. Advanced Medical Optics is a leader in LASIK vision correction surgery and surgical contact lenses. One analyst noted that the Company was a "depressed, distressed asset, not so much because of the product portfolio, but because of under-management and a cyclical, tough environment for Lasik." Advanced Medical Optics stock had traded at more than $22 per share within the past four months.

If you currently own Advanced Medical Optics common stock and would like a free consultation concerning your rights and interests, please contact Kip Shuman, Esq. or Rusty Glenn, Esq. toll-free at 866-974-8626 or email Mr. Shuman at kip@shumanlawfirm.com or Mr. Glenn at rusty@shumanlawfirm.com.

The Shuman Law Firm represents investors throughout the nation, concentrating its practice in securities class actions and shareholder derivative litigation.